Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

CTLA4 as Immunological Checkpoint in the Development of Multiple Sclerosis.
[Factors Influencing Lead Time in Multiple Sclerosis: Survey of Members of the German Multiple Sclerosis Society in Saxony-Anhalt].
Bedside to bench to bedside research: Estrogen receptor beta ligand as a candidate neuroprotective treatment for multiple sclerosis.
Multiple Sclerosis Patients Valuing Their Own Health Status: Valuation and Psychometric Properties of the 15D.
Gender effect on neuromyelitis optica spectrum disorder with aquaporin4-immunoglobulin G.
The increased antibody response to Epstein-Barr virus in multiple sclerosis is restricted to selected virus proteins.
Treatment of surgical brain injury by immune tolerance induced by intrathymic and hepatic portal vein injection of brain antigens.
Retinal imaging and axonal degeneration in later onset multiple sclerosis.
A new role for the P2Y-like GPR17 receptor in the modulation of multipotency of oligodendrocyte precursor cells in vitro.
Survey of US Patients with Multiple Sclerosis: Comparison of the New Electronic Interferon Beta-1b Autoinjector (BETACONNECT™) With Mechanical Autoinjectors.
Oxidative damage and chemokine production dominate days before immune cell infiltration and EAE disease debut.
Sudden hearing loss as the initial symptom in Japanese patients with multiple sclerosis and seropositive neuromyelitis optica spectrum disorders.
Autophagy Is Involved in the Sevoflurane Anesthesia-Induced Cognitive Dysfunction of Aged Rats.
Plasticity Related Gene 3 (PRG3) overcomes myelin-associated growth inhibition and promotes functional recovery after spinal cord injury.
Myelin Oligodendrocyte Glycoprotein Antibody Persistency in a Steroid-Dependent ADEM Case.
[Clinical and demographic characteristics of patients with multiple sclerosis].
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy.
A high throughput drug screening assay to identify compounds that promote oligodendrocyte differentiation using acutely dissociated and purified oligodendrocyte precursor cells.
CSF neurofilament light: A universal risk biomarker in multiple sclerosis?
Exercise and Alzheimer's Disease, Parkinson's Disease, and Multiple Sclerosis.
Acute flaccid weakness with myelopathy and peripheral nerve involvement in 2 children: Recent characterization of a previously observed phenomenon.
Screening and characterization of molecules that modulate the biological activity of IFNs-I.
To fingolimod and beyond: The rich pipeline of drug candidates that target S1P signaling.
Fine specificity of the antibody response to Epstein-Barr nuclear antigen-2 and other Epstein-Barr virus proteins in patients with clinically isolated syndrome: A peptide microarray-based case-control study.
Dietary Interventions in Multiple Sclerosis: Development and Pilot-Testing of an Evidence Based Patient Education Program.

Pages